Maria João Cardoso, Breast Cancer Research Program Director at BCRP Champalimaud Foundation and International Coordinator of Cinderella Project, shared Rui Miguel Nabeiro’s, CEO at Delta Cafés, post on LinkedIn, adding:
“The associations of our daily habits with cancer are becoming a very important foccus of research.
Although coffee is a part of our lives and it has been related to better outcomes in some cancers it needs additional research.
The Breast Cancer Research Program (BCRP) – Champalimaud Foundation is thrilled that the Portuguese brand Delta Cafés will support our line of research on the potential benefits of coffee in breast cancer.
Thank you on behalf of our most important goal! Improve the outcomes of all those affected by Breast Cancer. Champalimaud Foundation”
Quoting Rui Miguel Nabeiro’s post:
“Today we signed a protocol with Champalimaud Foundation to support the Breast Cancer Research Programme and to initiate a scientific study on the impact of coffee consumption on the prevention, treatment and survival of this disease.
Coffee is part of the lives of millions of people, every day. And we believe that it makes sense to deepen, with the rigor of science, the knowledge about its role in health and well-being.
Getting to know the work of the Champalimaud Foundation up close further reinforced our conviction that investing in research is investing in people’s future.
It is a privilege to be able to contribute to a project with this scientific and human dimension.”
Other articles featuring Maria João Cardoso and Champalimaud Foundation on OncoDaily.
